Skip to content

Incyte INCY PEG ratio

PEG ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×
Gilead Sciences logo
Gilead SciencesGILD
0.3×+0.3×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.2×
Amgen logo
AmgenAMGN
0.8×+0.3×
Biogen logo
BiogenBIIB
0.4×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
8.6×+7.1×

Other financials

Income statement

See full
Revenue$1.3B+20.9%
Gross profit$1.2B+19.2%
Operating income$301.1M+46.8%
Net income$303.3M+91.7%
EPS (diluted)$1.47+83.8%

Balance sheet

See full
Cash & equivalents$3.5B+78.2%
Total debt$39.4M-8.6%
Total equity$5.6B+53.3%
Total assets$7.3B+27.7%

Cash flow

See full
Operating cash flow$369.4M+38.8%
CapEx$1.6M-43.5%
Free cash flow$367.7M+39.7%

Valuation

See full
Market cap$19.62B+59.9%
Enterprise value$16.2B+55.9%
P/E13.7×-564×
P/S3.7×+0.9×

Profitability

See full
Gross margin92.5%-0.2pp
Operating margin30%+26.1pp
Net margin26.7%+26.2pp

Returns & leverage

See full
Return on equity30.8%+30.4pp
Debt / equity0.0×
Current ratio3.7×+1.6×

Where this comes from

Calculated from Incyte’s reported figures.

Based on the most recent quarter.

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's PEG ratio?
Incyte (INCY) reported PEG ratio of 0× in Q1 2026.
What does PEG ratio mean?
The P/E ratio adjusted for how fast earnings are growing.
How do you interpret PEG ratio?
Around 1.0 is often cited as fairly valued for the growth on offer; below 1.0 can flag a growth bargain. Highly sensitive to the growth input and meaningless when growth is zero or negative.
How does PEG ratio compare across companies?
A rough cross-company growth-adjusted screen; treat as directional given its sensitivity to the (trailing) growth basis.